Announcements

Shell Springboard regional winner Ventive secures £900,000 funding
Dr Christine Wilkinson Blanc joins Psioxus Therapeutics as Chief Medical Officer
Mercia Fund Management announces Carlton Jones as nanoTherics’ CEO
Mercia Fund Management announces first SEIS investments from the Mercia Growth Fund 1
Oxford’s Native Antigen Company receives funding boost
Mercia Fund Management announces its first EIS investments from Mercia Growth Fund 1
Why SEIS is particularly attractive for 2013/14
Mercia Fund Management holds first Open House for SEIS and EIS investees
PolyTherics receives milestone payment as Celtic Pharma progresses development of long-acting version of Blood Factor VIII produced using PolyTherics’ TheraPEG™ technology
Mercia Fund Management launches Mercia Growth Fund 2 – a new hybrid EIS/SEIS investment opportunity